Glassman Wealth Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,215
Closed -$31.9K 1284
2023
Q4
$31.9K Buy
2,215
+419
+23% +$5.7K ﹤0.01% 571
2023
Q3
$31.2K Buy
1,796
+131
+8% +$2.73K 0.01% 547
2023
Q2
$34.6K Buy
1,665
+448
+37% +$9.74K 0.01% 495
2023
Q1
$28.6K Buy
1,217
+62
+5% +$1.67K 0.01% 539
2022
Q4
$32.3K Buy
1,155
+450
+64% +$11.5K 0.01% 535
2022
Q3
$17K Sell
705
-353
-33% -$10.7K ﹤0.01% 670
2022
Q2
$36K Buy
+1,058
New +$37.1K 0.01% 464
2022
Q1
Sell
-1,581
Closed -$48K 1856
2021
Q4
$48K Buy
1,581
+832
+111% +$27.1K 0.01% 383
2021
Q3
$25K Buy
749
+104
+16% +$3.33K 0.01% 528
2021
Q2
$20K Buy
+645
New +$21.2K ﹤0.01% 572

Other funds holding OGN

Glassman Wealth Services's OGN Position: Q1 2024 in Review

Glassman Wealth Services sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 2,215 shares — an estimated $31.9K sold.

Glassman Wealth Services first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $48K in Q4 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Glassman Wealth Services reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 2,215 Organon & Co shares in Q1 2024, an estimated $31.9K.
  • Glassman Wealth Services first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Glassman Wealth Services's Organon & Co position peaked at $48K in Q4 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.